Rosa Montesinos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rosa Montesinos has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Nilton Custodio
Research Unit, Instituto Peruano de Neurociencias, Lima, Peru
47 shared publications - David Lira
Servicio de Neurología, Instituto Peruano de Neurociencias, Lima, Peru
17 shared publications - Eder Herrera-Perez
Unidad de Investigación, Instituto Peruano de Neurociencias, Lima, Peru
15 shared publications David Lira
Servicio de Neurología, Instituto Peruano de Neurociencias, Lima, Peru
10 shared publications- Sheila Castro-Suarez
Global Brain Health Institute (GBHI), University of California San Francisco, San Francisco, CA, USA
10 shared publications - Marco Malaga
Instituto Peruano de Neurociencias, Perú
8 shared publications
Latest Publications
- 23 July 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 113 (1) , 224-233
Recruitment challenges and strategies for engaging the Peruvian population in the ReDLat Study
Background: Recruitment for Alzheimer's disease and related dementias research remains challenging, particularly when reaching underrepresented groups such as Latin Americans. Objective: This study aimed to (1) assess recruitment rates across strategies in the ReDLat study and (2) discuss lessons learned to inform future recruitment practices. Methods: This retrospective study outlines the recruitment for ReDLat, a multi-partner consortium expanding dementia research in Latin America. Participants were recruited using: printed flyers, social media, word-of-mouth, and professional referrals. At initial contact, participants were asked how they learned about the study. Enrollment rates were calculated for each source, and differences across sources were examined using a Pearson chi-square test. Results: Between January 2023 and March 2025, 577 individuals expressed interest, of whom 69% (n = 397) were enrolled. Enrollment rates differed significantly across sources (χ 2 (3) = 41.66, p < 0.001); professional referrals achieved a substantially higher rate (81%) than printed flyers (51%), social media (55%), and word-of-mouth (60%), which showed broadly comparable rates. Printed flyers and social media generated broad interest but lower enrollment conversion. Among the 180 individuals not enrolled, the most frequent reason for non-participation was failure to meet inclusion criteria (54%), particularly among those reached via social media and word-of-mouth. Loss of contact accounted for 36% of non-participation. Conclusions: Professional referrals were associated with the highest enrollment rate for the ReDLat study. These findings highlight the importance of leveraging community trust and professional networks to improve recruitment outcomes for dementia research in underrepresented populations.
- 23 July 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 113 (1) , 224-233
Recruitment challenges and strategies for engaging the Peruvian population in the ReDLat Study
Background: Recruitment for Alzheimer's disease and related dementias research remains challenging, particularly when reaching underrepresented groups such as Latin Americans. Objective: This study aimed to (1) assess recruitment rates across strategies in the ReDLat study and (2) discuss lessons learned to inform future recruitment practices. Methods: This retrospective study outlines the recruitment for ReDLat, a multi-partner consortium expanding dementia research in Latin America. Participants were recruited using: printed flyers, social media, word-of-mouth, and professional referrals. At initial contact, participants were asked how they learned about the study. Enrollment rates were calculated for each source, and differences across sources were examined using a Pearson chi-square test. Results: Between January 2023 and March 2025, 577 individuals expressed interest, of whom 69% (n = 397) were enrolled. Enrollment rates differed significantly across sources (χ 2 (3) = 41.66, p < 0.001); professional referrals achieved a substantially higher rate (81%) than printed flyers (51%), social media (55%), and word-of-mouth (60%), which showed broadly comparable rates. Printed flyers and social media generated broad interest but lower enrollment conversion. Among the 180 individuals not enrolled, the most frequent reason for non-participation was failure to meet inclusion criteria (54%), particularly among those reached via social media and word-of-mouth. Loss of contact accounted for 36% of non-participation. Conclusions: Professional referrals were associated with the highest enrollment rate for the ReDLat study. These findings highlight the importance of leveraging community trust and professional networks to improve recruitment outcomes for dementia research in underrepresented populations.
- Open Access
- 3 June 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (6) , e71550
Validity of the two different scoring methods of the Clinical Dementia Rating scale in staging and detection of cognitive impairment in the Peruvian population
INTRODUCTION: In Peru, the Global Deterioration Scale is the only available tool for assessing dementia severity. The Spanish translation and cultural adaptation of the Clinical Dementia Rating (CDR) is used locally but requires formal psychometric validation in the Peruvian sociocultural context. METHODS: A total of 1,600 older adults: 902 controls, 271 mild cognitive impairment (MCI), and 427 Alzheimer's disease patients (AD) were assessed to validate two CDR scoring methods: CDR Global Score (CDR‐GS) and CDR Sum of Boxes Score (CDR‐SB). Discriminative validity, inter‐item reliability, and concurrent validity were evaluated using MMSE, RUDAS, PFAQ, and Uniform Data Set (UDS) v3 Neuropsychological Battery. RESULTS: CDR demonstrated high reliability and validity among normal cognition, mild cognitive impairment, and AD. For AD screening, CDR‐SB showed 98.2% sensitivity and 99.6% specificity, while CDR‐GS demonstrated 99.8% sensitivity and 100% specificity. DISCUSSION: The Peruvian CDR version exhibited good psychometric properties comparable to those reported in Latin American CDR validation studies.
- 3 June 2026
- Published by Wiley in Alzheimer's & Dementia
- Vol. 22 (6) , e71550
Open AccessValidity of the two different scoring methods of the Clinical Dementia Rating scale in staging and detection of cognitive impairment in the Peruvian population
INTRODUCTION: In Peru, the Global Deterioration Scale is the only available tool for assessing dementia severity. The Spanish translation and cultural adaptation of the Clinical Dementia Rating (CDR) is used locally but requires formal psychometric validation in the Peruvian sociocultural context. METHODS: A total of 1,600 older adults: 902 controls, 271 mild cognitive impairment (MCI), and 427 Alzheimer's disease patients (AD) were assessed to validate two CDR scoring methods: CDR Global Score (CDR‐GS) and CDR Sum of Boxes Score (CDR‐SB). Discriminative validity, inter‐item reliability, and concurrent validity were evaluated using MMSE, RUDAS, PFAQ, and Uniform Data Set (UDS) v3 Neuropsychological Battery. RESULTS: CDR demonstrated high reliability and validity among normal cognition, mild cognitive impairment, and AD. For AD screening, CDR‐SB showed 98.2% sensitivity and 99.6% specificity, while CDR‐GS demonstrated 99.8% sensitivity and 100% specificity. DISCUSSION: The Peruvian CDR version exhibited good psychometric properties comparable to those reported in Latin American CDR validation studies.
- Open Access
- 11 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (05) , 001-009
Cognitive impairment on the Alzheimer's Disease Centers' Uniform Data Set Version 3 Neuropsychological Test Battery in a Peruvian population with progressive supranuclear palsy
Research on the cognitive profile in progressive supranuclear palsy (PSP) has been scarce in Latin America. To outline the demographic, clinical, and cognitive profile of Peruvian PSP patients living in Lima, Peru. We sought to determine the relationship between first clinical symptoms and specific cognitive abilities. A cross-sectional study of 34 PSP subjects. We used the Uniform Data Set Version 3 Neuropsychological Battery (UDS3-NB), which possesses normative data for the Peruvian population, to assess global and specific cognitive functions. We also performed correlation analyses to determine the relationship between presenting clinical symptoms (parkinsonism, postural instability, and cognitive impairment) and cognitive functioning. The mean age was 68 years, and mean schooling was 12.1 years in this cohort. The most common initial clinical symptom was parkinsonism (55.9%), followed by postural instability (23.5%) and dementia (20.6%). Our cohort showed poor performance on global cognition, with selective impairment of processing speed, executive function, and episodic memory. Attentional and visuospatial skills were mildly affected, with partial preservation of naming. There was no significant relationship between the initial clinical symptoms and global cognition, except for a slight correlation between parkinsonism and visuospatial function (r = 0.18; p < 0.05). We found that PSP patients in Peru had extensive impairment in executive function, processing speed, and episodic memory, with relatively preserved naming, consistent with other international cohorts. We did not find a correlation between initial clinical signs and cognitive profile, suggesting that an interdisciplinary approach is needed to evaluate patients with suspicion for PSP. Longitudinal studies are needed to more clearly define the progression of neuropsychiatric symptoms in PSP patients.
- 11 March 2026
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 84 (05) , 001-009
Open AccessCognitive impairment on the Alzheimer's Disease Centers' Uniform Data Set Version 3 Neuropsychological Test Battery in a Peruvian population with progressive supranuclear palsy
Research on the cognitive profile in progressive supranuclear palsy (PSP) has been scarce in Latin America. To outline the demographic, clinical, and cognitive profile of Peruvian PSP patients living in Lima, Peru. We sought to determine the relationship between first clinical symptoms and specific cognitive abilities. A cross-sectional study of 34 PSP subjects. We used the Uniform Data Set Version 3 Neuropsychological Battery (UDS3-NB), which possesses normative data for the Peruvian population, to assess global and specific cognitive functions. We also performed correlation analyses to determine the relationship between presenting clinical symptoms (parkinsonism, postural instability, and cognitive impairment) and cognitive functioning. The mean age was 68 years, and mean schooling was 12.1 years in this cohort. The most common initial clinical symptom was parkinsonism (55.9%), followed by postural instability (23.5%) and dementia (20.6%). Our cohort showed poor performance on global cognition, with selective impairment of processing speed, executive function, and episodic memory. Attentional and visuospatial skills were mildly affected, with partial preservation of naming. There was no significant relationship between the initial clinical symptoms and global cognition, except for a slight correlation between parkinsonism and visuospatial function (r = 0.18; p < 0.05). We found that PSP patients in Peru had extensive impairment in executive function, processing speed, and episodic memory, with relatively preserved naming, consistent with other international cohorts. We did not find a correlation between initial clinical signs and cognitive profile, suggesting that an interdisciplinary approach is needed to evaluate patients with suspicion for PSP. Longitudinal studies are needed to more clearly define the progression of neuropsychiatric symptoms in PSP patients.
- Open Access
- 25 February 2026
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 31 (4)
Cognitive changes associated with chemotherapy in breast cancer: an assessment of social cognition and executive functions in Peruvian patients
Background: Cognitive impairment related to chemotherapy—commonly referred to as “chemo brain”—is a well-documented phenomenon among breast cancer patients. These impairments affect memory, attention, executive function, and social cognition, yet remain understudied in low- and middle-income countries. In Peru, where populations present a high proportion of Amerindian ancestry and distinct sociocultural factors, evidence is scarce. Methods: We conducted a longitudinal study of 143 Peruvian women aged 28-64 years, newly diagnosed with early-stage breast cancer and naïve to chemotherapy, treated at the National Institute of Neoplastic Diseases (INEN) in Lima. Cognitive function was assessed using the Addenbrooke’s Cognitive Examination (ACE), the INECO Frontal Screening Test (IFS), and a Facial Emotion Recognition (FER) task to evaluate social cognition. Baseline tests were performed before the start of treatment for each patient, and post-treatment tests were performed every 3 months. Global genetic ancestry was estimated using the ADMIXTURE algorithm based on the Affymetrix Precision Medicine Research Array. Results: Native American ancestry accounted for 77.8% of the study population. Post-chemotherapy assessments revealed cognitive impairment in 21% of patients based on FER, 15% on ACE, and 12% on IFS. Higher educational attainment was associated with better cognitive performance across all domains. Conclusion: Chemotherapy was associated with measurable cognitive decline in a subset of Peruvian breast cancer patients. Brief and culturally adaptable tools such as the FER test offer a promising approach for routine cognitive screening in oncology settings, particularly in resource-limited contexts. Incorporating these assessments into standard care may facilitate early detection and more personalized supportive interventions.
- 25 February 2026
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 31 (4)
Open AccessCognitive changes associated with chemotherapy in breast cancer: an assessment of social cognition and executive functions in Peruvian patients
Background: Cognitive impairment related to chemotherapy—commonly referred to as “chemo brain”—is a well-documented phenomenon among breast cancer patients. These impairments affect memory, attention, executive function, and social cognition, yet remain understudied in low- and middle-income countries. In Peru, where populations present a high proportion of Amerindian ancestry and distinct sociocultural factors, evidence is scarce. Methods: We conducted a longitudinal study of 143 Peruvian women aged 28-64 years, newly diagnosed with early-stage breast cancer and naïve to chemotherapy, treated at the National Institute of Neoplastic Diseases (INEN) in Lima. Cognitive function was assessed using the Addenbrooke’s Cognitive Examination (ACE), the INECO Frontal Screening Test (IFS), and a Facial Emotion Recognition (FER) task to evaluate social cognition. Baseline tests were performed before the start of treatment for each patient, and post-treatment tests were performed every 3 months. Global genetic ancestry was estimated using the ADMIXTURE algorithm based on the Affymetrix Precision Medicine Research Array. Results: Native American ancestry accounted for 77.8% of the study population. Post-chemotherapy assessments revealed cognitive impairment in 21% of patients based on FER, 15% on ACE, and 12% on IFS. Higher educational attainment was associated with better cognitive performance across all domains. Conclusion: Chemotherapy was associated with measurable cognitive decline in a subset of Peruvian breast cancer patients. Brief and culturally adaptable tools such as the FER test offer a promising approach for routine cognitive screening in oncology settings, particularly in resource-limited contexts. Incorporating these assessments into standard care may facilitate early detection and more personalized supportive interventions.
- 21 January 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 109 (4) , 1790-1798
Perceptions of Peruvian neurologists toward the implementation of anti-amyloid drugs for early Alzheimer's disease in the departments of neurology
Background: Alzheimer's disease (AD) is a neurodegenerative disease affecting millions globally, with particular severity in low- and middle-income countries due to barriers in timely diagnosis and treatment. To date, two monoclonal anti-amyloids have shown positive results in phase III clinical trials. However, their administration is complex, requiring specialized infrastructure, highly trained professionals, and regular follow-ups, posing major challenges for healthcare systems. Objective: This study explores Peruvian neurologists’ perceptions of changes needed to implement monoclonal antibodies in line with clinical guidelines. Methods: A cross-sectional study was conducted in Peru using the key informant (KI) methodology. KI were neurologists from multiple regions across the country. A comprehensive list of tertiary-level hospitals (public healthcare system, social security, and police and armed forces) was compiled, and at least one neurologist from each institution was contacted. The instrument used was adapted from a study conducted in Spain, which included questions focusing on changes in diagnosis, patient care, diagnostic and therapeutic techniques, public and family impact, neurology resources, and dementia research. Data analysis was employed using Stata18, using descriptive statistics and frequency distributions. Results: Twenty-eight neurologists completed the survey. There was consensus on the significant impact monoclonal antibodies would have on neurology services. Over 85% agreed that more neurologists and nurses would be needed. Additionally, 93% supported using brief diagnostic scales in primary care and increasing follow-up visit frequency. Conclusions: The introduction of monoclonal antibodies for AD in Peru requires modifications to healthcare institutions, highlighting the urgent need for strategic healthcare planning.
- 21 January 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 109 (4) , 1790-1798
Perceptions of Peruvian neurologists toward the implementation of anti-amyloid drugs for early Alzheimer's disease in the departments of neurology
Background: Alzheimer's disease (AD) is a neurodegenerative disease affecting millions globally, with particular severity in low- and middle-income countries due to barriers in timely diagnosis and treatment. To date, two monoclonal anti-amyloids have shown positive results in phase III clinical trials. However, their administration is complex, requiring specialized infrastructure, highly trained professionals, and regular follow-ups, posing major challenges for healthcare systems. Objective: This study explores Peruvian neurologists’ perceptions of changes needed to implement monoclonal antibodies in line with clinical guidelines. Methods: A cross-sectional study was conducted in Peru using the key informant (KI) methodology. KI were neurologists from multiple regions across the country. A comprehensive list of tertiary-level hospitals (public healthcare system, social security, and police and armed forces) was compiled, and at least one neurologist from each institution was contacted. The instrument used was adapted from a study conducted in Spain, which included questions focusing on changes in diagnosis, patient care, diagnostic and therapeutic techniques, public and family impact, neurology resources, and dementia research. Data analysis was employed using Stata18, using descriptive statistics and frequency distributions. Results: Twenty-eight neurologists completed the survey. There was consensus on the significant impact monoclonal antibodies would have on neurology services. Over 85% agreed that more neurologists and nurses would be needed. Additionally, 93% supported using brief diagnostic scales in primary care and increasing follow-up visit frequency. Conclusions: The introduction of monoclonal antibodies for AD in Peru requires modifications to healthcare institutions, highlighting the urgent need for strategic healthcare planning.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 20, e2025377
The modified Rowland Universal Dementia Assessment Scale for dementia screening in the Peruvian population
Dementia cases are rising globally, particularly in low- and middle-income countries like those in Latin America. Objective: The aim of the study was to enhance diagnostic accuracy in diverse populations; modifications to brief cognitive tools may be necessary. Methods: This cross-sectional study involved 197 participants who underwent neurocognitive assessments with both the Peruvian version of the Rowland Universal Dementia Assessment Scale (RUDAS-PE) and a modified version of RUDAS-PE (mRUDAS-PE). Statistical analyses, including chi-square tests and receiver-operator curves, were used to compare the diagnostic performance of the original and modified RUDAS. Results: The mRUDAS-PE showed improved performance in the visuospatial construction domain, with more participants achieving top scores, especially among controls and Alzheimer’s disease patients. The judgment domain also yielded higher scores for controls. Only the judgment domain modifications do not change the diagnostic accuracy. Conclusion: Judgment modifications could be considered to improve the diagnostic performance of RUDAS-PE. Further testing in populations with different educational levels from rural areas is needed to assess their broader impact.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 20, e2025377
Open AccessThe modified Rowland Universal Dementia Assessment Scale for dementia screening in the Peruvian population
Dementia cases are rising globally, particularly in low- and middle-income countries like those in Latin America. Objective: The aim of the study was to enhance diagnostic accuracy in diverse populations; modifications to brief cognitive tools may be necessary. Methods: This cross-sectional study involved 197 participants who underwent neurocognitive assessments with both the Peruvian version of the Rowland Universal Dementia Assessment Scale (RUDAS-PE) and a modified version of RUDAS-PE (mRUDAS-PE). Statistical analyses, including chi-square tests and receiver-operator curves, were used to compare the diagnostic performance of the original and modified RUDAS. Results: The mRUDAS-PE showed improved performance in the visuospatial construction domain, with more participants achieving top scores, especially among controls and Alzheimer’s disease patients. The judgment domain also yielded higher scores for controls. Only the judgment domain modifications do not change the diagnostic accuracy. Conclusion: Judgment modifications could be considered to improve the diagnostic performance of RUDAS-PE. Further testing in populations with different educational levels from rural areas is needed to assess their broader impact.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 20, e20240270
Dementia knowledge among caregivers with and without training in Lima-Peru
Dementia prevalence is increasing globally, especially in low- and middle-income countries like Peru. Evidence has shown that a trained caregiver improves the patient’s quality of life, reduces behavioral symptoms, and decreases the likelihood of the caregiver developing burnout. Objective: The aim of the study was to measure the level of knowledge of caregivers attending monthly training compared to untrained caregivers in Lima, Peru. Methods: A cross-sectional study was conducted involving 102 informal caregivers of dementia patients, split evenly into trained (n=51) and untrained (n=51) groups. The training program ("Lonchecito para cuidadores") consists of 10 virtual meetings per year, where the main topics are: types of dementia, management of behavioral symptoms, application of non-pharmacological measures, and caregiver well-being. Dementia knowledge was assessed using the Spanish version of the Dementia Knowledge Assessment Scale (DKAS-S). Data were analyzed using Student’s t-test to compare group scores, with a significance threshold of p<0.05. Results: The trained caregivers scored higher [mean=18, standard deviation (SD)=2.72] than the untrained group (mean=16, SD=2.6) (p=0.001). Higher education was moderately correlated with better DKAS-S scores. Notably, questions on early dementia symptoms, advanced care, and management of behavioral symptoms had the highest error rates, with up to 70% incorrect responses on some items. Conclusion: Caregivers with dementia training performed better than the general population, underscoring the need for improved community access to quality dementia information.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 20, e20240270
Open AccessDementia knowledge among caregivers with and without training in Lima-Peru
Dementia prevalence is increasing globally, especially in low- and middle-income countries like Peru. Evidence has shown that a trained caregiver improves the patient’s quality of life, reduces behavioral symptoms, and decreases the likelihood of the caregiver developing burnout. Objective: The aim of the study was to measure the level of knowledge of caregivers attending monthly training compared to untrained caregivers in Lima, Peru. Methods: A cross-sectional study was conducted involving 102 informal caregivers of dementia patients, split evenly into trained (n=51) and untrained (n=51) groups. The training program ("Lonchecito para cuidadores") consists of 10 virtual meetings per year, where the main topics are: types of dementia, management of behavioral symptoms, application of non-pharmacological measures, and caregiver well-being. Dementia knowledge was assessed using the Spanish version of the Dementia Knowledge Assessment Scale (DKAS-S). Data were analyzed using Student’s t-test to compare group scores, with a significance threshold of p<0.05. Results: The trained caregivers scored higher [mean=18, standard deviation (SD)=2.72] than the untrained group (mean=16, SD=2.6) (p=0.001). Higher education was moderately correlated with better DKAS-S scores. Notably, questions on early dementia symptoms, advanced care, and management of behavioral symptoms had the highest error rates, with up to 70% incorrect responses on some items. Conclusion: Caregivers with dementia training performed better than the general population, underscoring the need for improved community access to quality dementia information.
- Open Access
- 25 April 2025
- Published by Association for Computing Machinery (ACM)
- p. 1-21
Design and Development of a mHealth Dementia Screening Tool in Resource-Limited Settings
- 25 April 2025
- Published by Association for Computing Machinery (ACM)
- p. 1-21
Open AccessDesign and Development of a mHealth Dementia Screening Tool in Resource-Limited Settings
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 19, e20240232
Improving participants’ recruitment in dementia-related studies on social media through colloquial language in Lima, Peru
Recruitment for dementia research remains a persistent challenge, particularly when trying to reach underrepresented groups such as Latin Americans with traditional enrollment strategies. Objective: In this retrospective case study, we investigate two communication approaches used on social media to recruit participants for a dementia research study in Lima, Peru. Methods: Initially, recruitment materials featured medical terminology, which was later replaced by colloquial language to make the content more accessible. Results: According to the results, using simpler and more relatable language led to an increase in participants’ contacts and enrollments. This suggests that culturally tailored communication strategies may be more effective in reaching diverse populations. Conclusion: The findings highlight the importance of adapting research recruitment efforts to the target community’s cultural and linguistic context to improve engagement in dementia studies.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 19, e20240232
Open AccessImproving participants’ recruitment in dementia-related studies on social media through colloquial language in Lima, Peru
Recruitment for dementia research remains a persistent challenge, particularly when trying to reach underrepresented groups such as Latin Americans with traditional enrollment strategies. Objective: In this retrospective case study, we investigate two communication approaches used on social media to recruit participants for a dementia research study in Lima, Peru. Methods: Initially, recruitment materials featured medical terminology, which was later replaced by colloquial language to make the content more accessible. Results: According to the results, using simpler and more relatable language led to an increase in participants’ contacts and enrollments. This suggests that culturally tailored communication strategies may be more effective in reaching diverse populations. Conclusion: The findings highlight the importance of adapting research recruitment efforts to the target community’s cultural and linguistic context to improve engagement in dementia studies.
- Open Access
- 18 July 2024
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (09) , 001-009
Knowledge of dementia and Alzheimer's disease among healthcare professionals in Peru
Background Primary care physicians and other healthcare providers report feeling unprepared to treat persons with dementia (PWD), especially in developing countries Objective We aimed to assess the knowledge of dementia and Alzheimer's disease (AD) among health professionals in both primary and tertiary care in Peru. Methods We conducted an in-person and virtual survey of healthcare professionals trained in Peru throughout the year 2020. The survey was developed based on a previously published one and reviewed by an expert panel. We compared groups using a Chi-squared test. A Bonferroni corrected p-value of 0.008 was used for statistical significance. Results Out of 804 surveys, we excluded 56 due to incomplete data. A total of 41.6% of respondents were doctors and 21.8%, nurses. One fifth of participants did not recognize AD as a cause of dementia and over half considered “senile dementia” a valid clinical entity. Scores were higher among those with postgraduate training, multiple patients with dementia, or those who had practiced for over 10 years. Conclusion There is a low level of knowledge of dementia and AD among health professionals in Peru, which worsens outside of Lima. Pernicious ideas, such as senile dementia, are still significantly present among respondents.
- 18 July 2024
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 82 (09) , 001-009
Open AccessKnowledge of dementia and Alzheimer's disease among healthcare professionals in Peru
Background Primary care physicians and other healthcare providers report feeling unprepared to treat persons with dementia (PWD), especially in developing countries Objective We aimed to assess the knowledge of dementia and Alzheimer's disease (AD) among health professionals in both primary and tertiary care in Peru. Methods We conducted an in-person and virtual survey of healthcare professionals trained in Peru throughout the year 2020. The survey was developed based on a previously published one and reviewed by an expert panel. We compared groups using a Chi-squared test. A Bonferroni corrected p-value of 0.008 was used for statistical significance. Results Out of 804 surveys, we excluded 56 due to incomplete data. A total of 41.6% of respondents were doctors and 21.8%, nurses. One fifth of participants did not recognize AD as a cause of dementia and over half considered “senile dementia” a valid clinical entity. Scores were higher among those with postgraduate training, multiple patients with dementia, or those who had practiced for over 10 years. Conclusion There is a low level of knowledge of dementia and AD among health professionals in Peru, which worsens outside of Lima. Pernicious ideas, such as senile dementia, are still significantly present among respondents.